vs
瑞思迈（RMD）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
Roper Technologies的季度营收约是瑞思迈的1.5倍（$2.1B vs $1.4B），瑞思迈净利率更高（27.6% vs 15.8%，领先11.8%），Roper Technologies同比增速更快（11.3% vs 11.0%），过去两年Roper Technologies的营收复合增速更高（10.5% vs 7.9%）
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
RMD vs ROP — 直观对比
营收规模更大
ROP
是对方的1.5倍
$1.4B
营收增速更快
ROP
高出0.3%
11.0%
净利率更高
RMD
高出11.8%
15.8%
两年增速更快
ROP
近两年复合增速
7.9%
损益表 — Q4 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $2.1B |
| 净利润 | $392.6M | $331.0M |
| 毛利率 | 61.8% | 69.4% |
| 营业利润率 | 34.6% | 27.2% |
| 净利率 | 27.6% | 15.8% |
| 营收同比 | 11.0% | 11.3% |
| 净利润同比 | 13.9% | 53.7% |
| 每股收益（稀释后） | $2.68 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RMDROP
| Q2 26 | $1.4B | — | ||
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.4B | $2.1B | ||
| Q3 25 | $1.3B | $2.0B | ||
| Q2 25 | $1.3B | $1.9B | ||
| Q1 25 | $1.3B | $1.9B | ||
| Q4 24 | $1.3B | $1.9B | ||
| Q3 24 | $1.2B | $1.8B |
净利润RMDROP
| Q2 26 | $392.6M | — | ||
| Q1 26 | — | $331.0M | ||
| Q4 25 | $392.6M | $428.4M | ||
| Q3 25 | $348.5M | $398.5M | ||
| Q2 25 | $379.7M | $378.3M | ||
| Q1 25 | $365.0M | $331.1M | ||
| Q4 24 | $344.6M | $462.3M | ||
| Q3 24 | $311.4M | $367.9M |
毛利率RMDROP
| Q2 26 | 61.8% | — | ||
| Q1 26 | — | 69.4% | ||
| Q4 25 | 61.8% | 69.5% | ||
| Q3 25 | 61.5% | 69.5% | ||
| Q2 25 | 60.8% | 69.2% | ||
| Q1 25 | 59.3% | 68.7% | ||
| Q4 24 | 58.6% | 68.3% | ||
| Q3 24 | 58.6% | 69.2% |
营业利润率RMDROP
| Q2 26 | 34.6% | — | ||
| Q1 26 | — | 27.2% | ||
| Q4 25 | 34.6% | 28.6% | ||
| Q3 25 | 33.4% | 28.4% | ||
| Q2 25 | 33.7% | 28.2% | ||
| Q1 25 | 33.0% | 27.9% | ||
| Q4 24 | 32.5% | 28.0% | ||
| Q3 24 | 31.6% | 28.1% |
净利率RMDROP
| Q2 26 | 27.6% | — | ||
| Q1 26 | — | 15.8% | ||
| Q4 25 | 27.6% | 20.8% | ||
| Q3 25 | 26.1% | 19.8% | ||
| Q2 25 | 28.2% | 19.5% | ||
| Q1 25 | 28.3% | 17.6% | ||
| Q4 24 | 26.9% | 24.6% | ||
| Q3 24 | 25.4% | 20.8% |
每股收益（稀释后）RMDROP
| Q2 26 | $2.68 | — | ||
| Q1 26 | — | $4.87 | ||
| Q4 25 | $2.68 | $3.97 | ||
| Q3 25 | $2.37 | $3.68 | ||
| Q2 25 | $2.58 | $3.49 | ||
| Q1 25 | $2.48 | $3.06 | ||
| Q4 24 | $2.34 | $4.29 | ||
| Q3 24 | $2.11 | $3.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $382.9M |
| 总债务越低越好 | $663.8M | $9.7B |
| 股东权益账面价值 | $6.3B | $18.8B |
| 总资产 | $8.5B | $34.6B |
| 负债/权益比越低杠杆越低 | 0.11× | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资RMDROP
| Q2 26 | $1.4B | — | ||
| Q1 26 | — | $382.9M | ||
| Q4 25 | $1.4B | $297.4M | ||
| Q3 25 | $1.4B | $320.0M | ||
| Q2 25 | $1.2B | $242.4M | ||
| Q1 25 | $932.7M | $372.8M | ||
| Q4 24 | $521.9M | $188.2M | ||
| Q3 24 | $426.4M | $269.6M |
总债务RMDROP
| Q2 26 | $663.8M | — | ||
| Q1 26 | — | $9.7B | ||
| Q4 25 | $403.9M | $9.3B | ||
| Q3 25 | $408.7M | — | ||
| Q2 25 | $658.4M | — | ||
| Q1 25 | $663.1M | — | ||
| Q4 24 | $662.9M | $7.6B | ||
| Q3 24 | $667.6M | — |
股东权益RMDROP
| Q2 26 | $6.3B | — | ||
| Q1 26 | — | $18.8B | ||
| Q4 25 | $6.3B | $19.9B | ||
| Q3 25 | $6.1B | $20.0B | ||
| Q2 25 | $6.0B | $19.6B | ||
| Q1 25 | $5.5B | $19.2B | ||
| Q4 24 | $5.3B | $18.9B | ||
| Q3 24 | $5.2B | $18.5B |
总资产RMDROP
| Q2 26 | $8.5B | — | ||
| Q1 26 | — | $34.6B | ||
| Q4 25 | $8.5B | $34.6B | ||
| Q3 25 | $8.3B | $34.6B | ||
| Q2 25 | $8.2B | $33.2B | ||
| Q1 25 | $7.6B | $31.4B | ||
| Q4 24 | $7.1B | $31.3B | ||
| Q3 24 | $7.2B | $31.6B |
负债/权益比RMDROP
| Q2 26 | 0.11× | — | ||
| Q1 26 | — | 0.52× | ||
| Q4 25 | 0.06× | 0.47× | ||
| Q3 25 | 0.07× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.13× | 0.40× | ||
| Q3 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | — |
| 自由现金流经营现金流 - 资本支出 | — | $507.0M |
| 自由现金流率自由现金流/营收 | — | 24.2% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流RMDROP
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $339.7M | $738.0M | ||
| Q3 25 | $457.3M | $869.5M | ||
| Q2 25 | $538.8M | $404.1M | ||
| Q1 25 | $578.7M | $528.7M | ||
| Q4 24 | $308.6M | $722.2M | ||
| Q3 24 | $325.5M | $755.4M |
自由现金流RMDROP
| Q2 26 | — | — | ||
| Q1 26 | — | $507.0M | ||
| Q4 25 | $311.2M | — | ||
| Q3 25 | $414.4M | — | ||
| Q2 25 | $508.2M | — | ||
| Q1 25 | $557.9M | — | ||
| Q4 24 | $288.0M | — | ||
| Q3 24 | $307.7M | — |
自由现金流率RMDROP
| Q2 26 | — | — | ||
| Q1 26 | — | 24.2% | ||
| Q4 25 | 21.9% | — | ||
| Q3 25 | 31.0% | — | ||
| Q2 25 | 37.7% | — | ||
| Q1 25 | 43.2% | — | ||
| Q4 24 | 22.5% | — | ||
| Q3 24 | 25.1% | — |
资本支出强度RMDROP
| Q2 26 | — | — | ||
| Q1 26 | — | 0.5% | ||
| Q4 25 | 2.0% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 1.5% | — |
现金转化率RMDROP
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 0.87× | 1.72× | ||
| Q3 25 | 1.31× | 2.18× | ||
| Q2 25 | 1.42× | 1.07× | ||
| Q1 25 | 1.59× | 1.60× | ||
| Q4 24 | 0.90× | 1.56× | ||
| Q3 24 | 1.05× | 2.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
